Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Journal of Registry Management|June 1, 2023
Are We Undercounting MDS? An Analysis of Incidence Patterns of Myelodysplastic Syndromes in SEER 21 Regions: 2001-2016Anshu Shrestha, Eric Stewart, Rosemary Cress
Cancer Causes & Control : CCC|April 4, 2008
Cancer risk in a cohort of patients with systemic lupus erythematosus (SLE) in CaliforniaArti Parikh-Patel, Richard H White, Mark Allen, et al.
European Urology Focus|May 9, 2018
Changing Incidence of Metastatic Prostate Cancer by Race and Age, 1988-2015Marc A Dall'Era, Ralph deVere-White, Danielle Rodriguez, et al.
American Journal of Obstetrics and Gynecology|October 31, 2003
Cancer associated with obstetric delivery: results of linkage with the California cancer registryLloyd H Smith, Beate Danielsen, Mark E Allen, et al.
Cancer Causes & Control : CCC|February 3, 2009
Risk of cancer among rheumatoid arthritis patients in CaliforniaArti Parikh-Patel, Richard H White, Mark Allen, et al.
Cancer|February 16, 2005
Malignant melanoma in pregnancy. A population-based evaluationAnne T O'Meara, Rosemary Cress, Guibo Xing, et al.
Cancer Causes & Control : CCC|June 23, 2010
Does socioeconomic disparity in cancer incidence vary across racial/ethnic groups?Daixin Yin, Cyllene Morris, Mark Allen, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|December 18, 2008
Pregnancy-associated colon and rectal cancer: perinatal and cancer outcomesMary T Dahling, Guibo Xing, Rosemary Cress, et al.
Urologic Oncology|June 9, 2023
Underutilization of intravesical chemotherapy and immunotherapy for high grade non-muscle invasive bladder cancer in California between 2006-2018: Effect of race, age and socioeconomic status on treatment disparitiesOnika Dv Noel, Eric Stewart, Rosemary Cress, et al.
Cancer|March 3, 2018
Nine-year prostate cancer survival differences between aggressive versus conservative therapy in men with advanced and metastatic prostate cancerMarc A Dall'Era, Mary J Lo, Jaclyn Chen, et al.
Pageof 4